Advent Access unveils Clinical Trial results at the American Society of Nephrology Kidney Week, 2018

27 Oct 2018

The full results of Advent Access's First-In-Human Clinical Trial of the av-Guardian device was released at the American Society of Nephrology (ASN) Kidney Week 2018. The ASN is lauded as the most premier nephrology meeting, involving 13,000 nephrologists and the world’s leading experts discussing the latest advances in the field.

   

Read more

 

 

 

Share on Facebook
Share on Twitter
Please reload

Recent Posts
Please reload

Archive
Please reload

©2019 By Advent Access Pte. Ltd. All Rights Reserved.